Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Operating Income (2020 - 2025)

RxSight (RXST) has disclosed Operating Income for 6 consecutive years, with $28.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income rose 27.65% year-over-year to $28.7 million, compared with a TTM value of -$8.2 million through Dec 2025, down 41.88%, and an annual FY2025 reading of -$8.2 million, down 41.86% over the prior year.
  • Operating Income was $28.7 million for Q4 2025 at RxSight, up from -$12.2 million in the prior quarter.
  • Across five years, Operating Income topped out at $28.7 million in Q4 2025 and bottomed at -$16.6 million in Q1 2022.
  • Average Operating Income over 5 years is -$9.0 million, with a median of -$12.8 million recorded in 2023.
  • The sharpest move saw Operating Income tumbled 76.62% in 2021, then soared 306.82% in 2024.
  • Year by year, Operating Income stood at -$14.7 million in 2021, then decreased by 2.23% to -$15.0 million in 2022, then grew by 27.51% to -$10.9 million in 2023, then surged by 306.82% to $22.5 million in 2024, then increased by 27.65% to $28.7 million in 2025.
  • Business Quant data shows Operating Income for RXST at $28.7 million in Q4 2025, -$12.2 million in Q3 2025, and -$14.0 million in Q2 2025.